These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 1929822)
1. In vivo measurement of breast cancer growth rate. Goodson WH; Ljung BM; Waldman F; Mayall B; Chew K; Moore DH; Smith H; Goldman ES; Benz C Arch Surg; 1991 Oct; 126(10):1220-3; discussion 1223-4. PubMed ID: 1929822 [TBL] [Abstract][Full Text] [Related]
2. Tumor labeling indices of primary breast cancers and their regional lymph node metastases. Goodson WH; Ljung BM; Moore DH; Mayall B; Waldman FM; Chew K; Benz CC; Smith HS Cancer; 1993 Jun; 71(12):3914-9. PubMed ID: 8508357 [TBL] [Abstract][Full Text] [Related]
3. [Epithelial growth factor receptors (EGF-R) and DNA flow cytometry in addition to lymph node and hormone receptor status as prognostic factors in primary breast cancer]. Costa SD; Kaufmann M; Fabbro D; Tokus M; Feichter G; Klinga K; Bastert G Geburtshilfe Frauenheilkd; 1989 Apr; 49(4):375-8. PubMed ID: 2544476 [TBL] [Abstract][Full Text] [Related]
4. The functional relationship between in vivo bromodeoxyuridine labeling index and Ki-67 proliferation index in human breast cancer. Goodson WH; Moore DH; Ljung BM; Chew K; Florendo C; Mayall B; Smith HS; Waldman FM Breast Cancer Res Treat; 1998 May; 49(2):155-64. PubMed ID: 9696398 [TBL] [Abstract][Full Text] [Related]
5. Apoptosis in breast carcinomas detected with monoclonal antibody to single-stranded DNA: relation to bcl-2 expression, hormone receptors, and lymph node metastases. Frankfurt OS; Robb JA; Sugarbaker EV; Villa L Clin Cancer Res; 1997 Mar; 3(3):465-71. PubMed ID: 9815706 [TBL] [Abstract][Full Text] [Related]
6. S-phase fractions of breast carcinomas. Relationships to morphology, estrogen and progesterone receptors, and early recurrence. Meyer JS; Bauer WC; Stevens SC; Rao BR; White WL Bull Cancer; 1978; 65(4):449-54. PubMed ID: 747801 [TBL] [Abstract][Full Text] [Related]
7. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer. Meyer JS; Province MA Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981 [TBL] [Abstract][Full Text] [Related]
8. Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction. A proposed classification of DNA histograms in breast cancer. Kallioniemi OP; Blanco G; Alavaikko M; Hietanen T; Mattila J; Lauslahti K; Lehtinen M; Koivula T Cancer; 1988 Nov; 62(10):2183-90. PubMed ID: 3179930 [TBL] [Abstract][Full Text] [Related]
10. Correlation of cell-cycle kinetics, hormone receptors, histopathology, and nodal status in human breast cancer. Moran RE; Black MM; Alpert L; Straus MJ Cancer; 1984 Oct; 54(8):1586-90. PubMed ID: 6478400 [TBL] [Abstract][Full Text] [Related]
11. 3H-thymidine labeling index, hormone receptors, and ploidy in breast cancers from elderly patients. Valentinis B; Silvestrini R; Daidone MG; Coradini D; Galante E; Cerrotta AM; Abolafio G; Arboit L Breast Cancer Res Treat; 1991 Dec; 20(1):19-24. PubMed ID: 1813066 [TBL] [Abstract][Full Text] [Related]
12. A proposed classification of breast cancer based on kinetic information: derived from a comparison of risk factors in 168 primary operable breast cancers. McDivitt RW; Stone KR; Craig RB; Palmer JO; Meyer JS; Bauer WC Cancer; 1986 Jan; 57(2):269-76. PubMed ID: 3942959 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of in vitro bromodeoxyuridine labeling of breast carcinomas with the use of a commercial kit. Lloveras B; Edgerton S; Thor AD Am J Clin Pathol; 1991 Jan; 95(1):41-7. PubMed ID: 1987751 [TBL] [Abstract][Full Text] [Related]
14. Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast. Friedman NS; Freedman MD Md Med J; 1994 Nov; 43(11):963-5. PubMed ID: 7808198 [TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical demonstration of S phase cells by anti-bromodeoxyuridine monoclonal antibody in human prostate adenocarcinoma. Nemoto R; Uchida K; Shimazui T; Hattori K; Koiso K; Harada M J Urol; 1989 Feb; 141(2):337-40. PubMed ID: 2643726 [TBL] [Abstract][Full Text] [Related]
16. nm23 expression in human breast cancer: correlation with cell proliferation (S-phase) as observed with a double-labeling immunocytochemical-autoradiographic technique. Simone G; Mangia A; Petroni S; Trotti I; Paradiso A; Marzullo F; De Lena M; Leone A Int J Oncol; 1998 May; 12(5):1055-9. PubMed ID: 9538128 [TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical determination of estrogen and progesterone receptors and flow cytometric DNA analysis of breast cancer on fine needle aspirates. Marrazzo A; Russo A; Bazan V; Taormina P; Lupo F; Bazan P Anticancer Res; 1993; 13(6B):2435-40. PubMed ID: 8135480 [TBL] [Abstract][Full Text] [Related]
18. Impact of flow cytometry on predicting recurrence and survival in breast cancer patients. McGuire Wl; Meyer JS; Barlogie B; Kute TE Breast Cancer Res Treat; 1985; 5(2):117-28. PubMed ID: 2410071 [No Abstract] [Full Text] [Related]
19. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer. Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956 [TBL] [Abstract][Full Text] [Related]
20. Ploidy, proliferative activity and estrogen receptor content in human breast cancer. Raber MN; Barlogie B; Latreille J; Bedrossian C; Fritsche H; Blumenschein G Cytometry; 1982 Jul; 3(1):36-41. PubMed ID: 7117052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]